exenatide twice daily (BID)

DRUG2 trials

Sponsors

AstraZeneca, Eli Lilly and Company

Conditions

Diabetes Mellitus, Type 2Type 2 Diabetes Mellitus

Phase 3

Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 Diabetes

CompletedNCT00434954

AstraZenecaType 2 Diabetes Mellitus

Start: 2007-02-28End: 2009-06-30Updated: 2015-04-07

Phase 4

A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)

TerminatedNCT02072096

Eli Lilly and CompanyDiabetes Mellitus, Type 2

Start: 2014-02-28End: 2015-10-31Updated: 2019-10-09

Related Papers

How many unpublished studies? ClinicalTrials.gov (n = 2614 studies): diabetes | Closed Studies | Interventional Studies | Phase 3, 4 | Search Date: Oct 27, 2014

Figshare2014-01-01

Exenatide twice daily: analysis of effectiveness and safety data stratified by age, sex, race, duration of diabetes, and body mass index.

2012-07-0143 citations